Bonnie Ky

2 weeks ago | tandfonline.com | Emily Anderson |Rachel J. Buchsbaum |Andreas Klein |Bonnie Ky

AbstractThe optimal treatment of patients with diffuse large B-cell lymphoma (DLBCL) or Hodgkin lymphoma (HL) with preexisting cardiomyopathy is uncertain. An anonymous, electronic survey was distributed by e-mail to three US lymphoma cooperative groups, two community hospitals, and twelve academic medical systems, and distributed at one international lymphoma meeting. Fifty hematology-oncology providers caring for patients with lymphoma were included.

2 months ago | jacc.org | Harlan M. Krumholz |Biykem Bozkurt |Y. Chandrashekhar |Bonnie Ky

JACC Journals › JACC › Archives › Just Accepted JACC. . Epublished DOI: 10.1016/j.jacc.2025.02.006FiguresReferencesRelatedDetails InformationCopyright © 2025, American College of Cardiology Foundation. Published by Elsevier Article History ReceivedFebruary 3, 2025AcceptedFebruary 3, 2025Published onlineFebruary 12, 2025

Oct 1, 2024 | jacc.org | Andriana P Nikolova |Bonnie Ky

References1. "Autoimmune myocarditis, old dogs and new tricks". Circ Res . 2024;134:1767-1790. https://doi.org/10.1161/CIRCRESAHA.124.323816. 2. "Immune checkpoint inhibitor myocarditis treatment strategies and future directions". JACC CardioOncol . 2022;4:704-707. https://doi.org/10.1016/j.jaccao.2022.11.005. 3. "The evolving immunotherapy landscape and the epidemiology, diagnosis, and management of cardiotoxicity". JACC CardioOncol . 2021;3:35-47. https://doi.org/10.1016/j.jaccao.2020.11.012. 4.

Apr 10, 2024 | nature.com | Bonnie Ky

AbstractCardiovascular disease (CVD) and cancer are among the leading causes of morbidity and mortality globally, and these conditions are increasingly recognized to be fundamentally interconnected. In this Review, we present the current epidemiological data for each of the modifiable risk factors shared by the two diseases, including hypertension, hyperlipidaemia, diabetes mellitus, obesity, smoking, diet, physical activity and the social determinants of health.

Apr 8, 2024 | healio.com | Scott Buzby |Richard Smith |Austin David |Bonnie Ky

Anita Deswal, MD, MPH, MBBS [Patients receiving 300 mg/m2 doxorubicin-equivalent or more are] an important patient population, the right patient population to look for, because of the dose. Biomarkers and troponin in previous studies suggested that [cardiac troponin I is] a good biomarker to predict whether patients will get cardiotoxicity or not, like LVEF going down. But those data were with regular troponin. These are with high-sensitivity troponin and I think we’re picking up noise.